Morepen Laboratories Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹484.72 crore, reflecting a quarter-on-quarter *(QoQ) increase of 0.12 per cent from ₹484.16 crore. This corresponds to a year-on-year *(YoY) growth of 4.05 per cent.
Operating Profit
Operating Profit stands at ₹24.45 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 47.22 per cent from ₹46.32 crore. This corresponds to a year-on-year *(YoY) decline of 42.12 per cent.
PBDT
PBDT stands at ₹29.04 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 36.61 per cent from ₹45.81 crore. This corresponds to a year-on-year *(YoY) decline of 31.17 per cent.
Profit Before Tax
Profit Before Tax stands at ₹23.29 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 34.26 per cent from ₹35.43 crore. This corresponds to a year-on-year *(YoY) decline of 9.45 per cent.
Net Profit
Net Profit stands at ₹15.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 42.91 per cent from ₹27.50 crore. This represents a 22.70 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Morepen Laboratories Ltd News
Morepen Laboratories Ltd Earnings
- YOY
- QOQ
Morepen Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Morepen Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Morepen Laboratories Ltd Financial Reports
Morepen Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Morepen Labs. | 2.07% | 5.90% | 25.86% | 47.08% | 30.89% | -15.36% |
| Panacea Biotec | 0.48% | 6.74% | 35.45% | 75.31% | 40.92% | 35.57% |
| Aarti Drugs | -0.20% | -1.10% | -4.70% | 12.60% | -9.72% | -17.81% |
| Unichem Labs. | -0.30% | -3.49% | 22.30% | 52.36% | -2.33% | -27.03% |
| Solara Active | -0.59% | -2.99% | 4.00% | 28.40% | 2.27% | -7.88% |
| Dishman Carbogen | -2.54% | -1.59% | -13.76% | 19.23% | -30.61% | -31.11% |
| Hikal | -2.01% | -1.76% | -2.59% | 37.72% | -5.42% | -40.82% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Sushil Suri
WTD & Executive Director : Sanjay Suri
Independent Non Exe. Director : Praveen Kumar Dutt
Independent Non Exe. Director : Ranjit Khattar
Independent Non Exe. Director : Savita
Independent Non Exe. Director : Sharad Jain
Company Secretary : Vipul Kumar Srivastava